Shalini Singh | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Shalini Singh | Medicine and Health Sciences | Best Researcher Award

Research Scholar, Gurukul Kangri, Deemed to be University, Haridwar, India

Mrs. Shalini Singh 🌸 is a highly accomplished scientific writer and researcher specializing in phytopharmacology 🌿, herbal medicine 🌼, and integrative therapeutics πŸ§ͺ. With a Master’s in Pharmacology πŸŽ“ and currently pursuing her Ph.D. 🎯 at Gurukula Kangri University, Haridwar, she has made outstanding contributions to academic and regulatory scientific writing πŸ“š. She worked at Patanjali Research Foundation 🌱 from 2018-2022, authoring numerous high-impact peer-reviewed articles, monographs, and dossiers. Mrs. Singh has collaborated with multidisciplinary teams πŸ‘©β€πŸ”¬, contributed to national and international initiatives like NMCG and AYUSH 🌍, and reviewed for top journals like Elsevier and Springer πŸ“. Her work bridges traditional wisdom and modern science, embodying excellence 🌟, dedication πŸ’ͺ, and innovation πŸ’‘. She continues to inspire through her research, scientific integrity, and pursuit of holistic healthcare solutions 🌏.

Publication Profile

Orcid

Experience

Mrs. Singh is a skilled Scientific Writer πŸ–‹οΈ who worked at Patanjali Research Foundation, Haridwar (May 2018–Nov 2022), where she authored peer-reviewed articles πŸ“„, pharmacological monographs πŸ“‘, systematic reviews πŸ“š, and regulatory documents πŸ›οΈ. She specialized in herbal medicine 🌿, clinical data analysis πŸ“Š, and scientific dossier preparation, demonstrating a strong command over both scientific detail and regulatory standards. Earlier, she served as an Assistant Professor πŸŽ“ at Lords International College of Pharmacy, Alwar (Dec 2017–April 2018), engaging in teaching πŸ“š, mentoring students 🎯, curriculum development ✍️, and academic research πŸ§ͺ. Throughout her career, Mrs. Singh collaborated with interdisciplinary teams 🀝, reviewed manuscripts for leading journals πŸ“°, and contributed to national projects initiated by the Ministry of AYUSH and the NMCG 🌐. Her work consistently reflects a unique blend of scientific rigor πŸ”¬, exceptional communication skills πŸ—£οΈ, and regulatory precision πŸ“, establishing her as an invaluable asset to the research community.

Awards and Honors

Mrs. Shalini Singh exemplifies academic excellence πŸ“š, leadership πŸ…, and a deep commitment to advancing healthcare research and Ayurvedic sciences 🌿. As a dedicated peer reviewer πŸ–ŠοΈ for prestigious journals like Elsevier, Springer, Wiley, Bentham Science, and Frontiers 🌍, she actively contributes to the scientific community. She has participated 🎀 in multiple national and international conferences 🌏, including “Modernization of Traditional Indian Medicine” 🌱, “Emerging Scenario of Science, Technology & Innovation-2023” πŸ”¬, and “Plants to Patients – Series 3: Rethinking Ethnopharmacology” 🌸. Her scholarly engagements extend further with her successful completion πŸ† of the DST-Sponsored STUTI Training Program at SATHI-BHU, Varanasi πŸŽ“. Mrs. Singh’s numerous participations, invited talks, and reviewer roles highlight her dynamic presence in the academic world, showcasing her drive to foster innovation and interdisciplinary collaboration. Her work continues to impact the fields of ethnopharmacology and traditional medicine, inspiring future researchers and practitioners alike 🌟.

Research Focus

Mrs. Shalini Singh’s research centers around phytopharmacology 🌱, herbal medicine 🌿, ethnopharmacology 🧬, and integrative therapeutics πŸ’Š. She has explored the anti-diabetic 🌟, anti-inflammatory πŸ§ͺ, and wound healing 🩹 potentials of natural products and traditional herbs. Her interest extends to modernizing Ayurvedic treatments πŸ§˜β€β™€οΈ through evidence-based studies, clinical evaluation πŸ“Š, and data synthesis from ethnobotanical sources πŸ“š. She has worked on national and global projects 🌏, authoring scientific dossiers, monographs, and manuscripts that bridge the gap between traditional medicine and contemporary healthcare practices 🧠. In addition to primary research, she emphasizes scientific communication πŸ–‹οΈ, regulatory documentation πŸ“‘, and the development of novel therapeutics πŸš€, making her a key player in promoting holistic, sustainable healthcare innovation 🌼.

Publication Top Notes

Research Articles:

  • πŸ“„ Evaluation of Anti-Diabetic activity of fruits of Withania coagulans in streptozotocin-induced diabetic rats.

  • πŸ“„ Anti-Hyperglycemic activity of Pithecellobium dules plant extracts on blood glucose levels of streptozotocin-induced diabetic rats.

  • πŸ“„ Effectiveness of Ayurvedic Regimens in Managing Polycystic Ovarian Syndrome and Related Comorbidities: An Observational Study.

  • πŸ“„ Exploring the Role of Herbo-mineral Combinations for the Management of Hypothyroidism.

  • πŸ“„ Elevating the Inner-Consciousness β€œThird Eye” Through β€œVedic Manas Yoga” Practice.

  • πŸ“„ Effect of various extracts from Ficus retusa L. stem bark on wound healing potential.

Review Articles:

  • πŸ“š Ayurvedic Approaches to Managing Premature Greying of Hair: A Comprehensive Review.

  • πŸ“š Small molecule inhibitors target multiple neuropathological signaling to exert novel neuroprotection in intracranial aneurysms.

  • πŸ“š Nature’s Signature in Ayurveda with an Ethnopharmacological Approach: A Narrative Review.

  • πŸ“š Nanotechnology in the Diagnosis and Management of Polycystic Ovary Syndrome: A Systematic Scoping Analysis.

  • πŸ“š Impact of Biosensors and Biomarkers in Diabetes Care: A Review.

  • πŸ“š Swertia chirayita (Roxb.) H. Karst.: A Magnificent Natural Remedy for Gastrointestinal Disorders.

  • πŸ“š Effect of Coliform Bacteria on Various Environmental Factors: A Review.

  • πŸ“š Hazardous Consequences and Management of Heavy Metals in Sewage Sludge: An Overview.

  • πŸ“š Withania coagulans Dunal.: A Narrative Review of an Anti-diabetic Shrub of the Desert Biome.

  • πŸ“š Bartogenic Acid: A Promising Pentacyclic Triterpenoid in Cancer Research and Possible Mechanism.

 

YONGFANG HU | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

YONGFANG HU | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr YONGFANG HU, Beijing Tsinghua Changgung Hospital, China

Assoc. Prof. Dr. Yongfang Hu is a distinguished clinical pharmacist and academic with over three decades of impactful service in pharmacy and pharmacology. πŸ“šπŸ§¬ She earned her degrees from Lanzhou University and Central South University, focusing on pharmacology and clinical pharmacology. πŸ’Š She has held prominent roles at leading institutions such as Lanzhou University, Peking University Third Hospital, and Tsinghua Changgung Hospital. 🌟 Her pioneering research covers pharmacogenomics, organ transplant pharmacotherapy, and elderly care medication. πŸ§ πŸ’‰ A highly respected scholar, she has authored influential publications and led studies on multidrug-resistant infections and personalized medicine. πŸ“ˆπŸ§« Dr. Hu’s commitment to advancing safe, effective drug therapies makes her a standout candidate for the Best Researcher Award. 🌐πŸ₯‡

Publication Profile

Orcid

Education

Dr. Yongfang Hu’s academic journey began with a Bachelor’s Degree in Pharmacy from the School of Pharmacy, Lanzhou University (1988). πŸŽ“πŸ’Š She further pursued a Master’s Degree in Pharmacology from the same institution in 2000, deepening her understanding of drug mechanisms and therapeutic strategies. πŸ”¬πŸ“˜ To solidify her expertise in clinical applications, she earned a Doctorate in Clinical Pharmacology from the Institute of Clinical Pharmacology, Central South University (2005). πŸ§¬πŸ“– Her academic training spans fundamental pharmacy, experimental pharmacology, and patient-centered pharmacotherapy, laying a strong foundation for her research in genomics, drug therapy, and personalized medicine. 🧠πŸ§ͺ Each milestone in her educational path reflects her lifelong dedication to pharmacological sciences and clinical excellence. πŸ…πŸ“š

Experience

From 1988 to 2002, Dr. Hu served as a Deputy Chief Pharmacist and Associate Professor at the Second Affiliated Hospital of Lanzhou University. πŸ₯πŸ“˜ She later joined Peking University Third Hospital (2005–2014) as a Chief Pharmacist and Associate Professor, advancing clinical pharmacy services and academic programs. πŸ§ͺπŸ“ˆ Between 2014 and 2015, she led the Pharmacy Department at Tsinghua Changgung Hospital, and since 2015, she continues there as a Chief Pharmacist and Associate Professor of Clinical Pharmacy. 🧬πŸ₯ Her clinical and academic leadership across top Chinese institutions showcases her expertise in implementing advanced pharmaceutical care and mentoring future pharmacists. πŸ’‘πŸŽ“

Awards and Honors

Dr. Hu has received multiple recognitions for her excellence in pharmacy and research. πŸ† In her tenure, she has been honored with Institutional Excellence Awards for Clinical Pharmacy Innovation and Outstanding Research Contributions at Peking University Third Hospital and Tsinghua Changgung Hospital. πŸŽ–οΈ She has been invited to serve on editorial boards and academic review committees, reflecting her standing in the scientific community. πŸ“šπŸ‘©β€βš•οΈ Her extensive work on drug genomics and personalized medicine has earned her accolades at national pharmacology conferences. 🧬🌟 These honors signify her continuous impact on both patient care and the broader medical research landscape. πŸ§ πŸ…

Research Focus

Dr. Hu’s research primarily focuses on the genomics of organ transplantation drugs and pharmacogenomics of thromboembolic diseases. πŸ§¬πŸ«€ She explores how genetic variations influence drug responses, aiming to tailor therapies for optimal patient outcomes. πŸ§ πŸ’Š She also delves into drug therapies for infectious diseases, including strategies to combat multidrug-resistant organisms, particularly in transplant patients. πŸ§«πŸ›‘οΈ Her work extends to cardiovascular pharmacotherapy and medication optimization in the elderly population, tackling polypharmacy and age-related metabolic changes. πŸ‘΅β€οΈ Through clinical studies and predictive modeling, Dr. Hu drives personalized medicine in real-world settings. πŸ“ŠπŸ” Her interdisciplinary approach bridges pharmacology, genomics, and patient care. πŸŒπŸ”—

Publication Top Notes

Epidemiology and Risk Prediction Model of Multidrug-Resistant Organism Infections After Liver Transplant Recipients: A Single-Center Cohort Study 🧫🧬

Yong Ahn | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Yong Ahn | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Yong Ahn, Kyung Hee University Hospital, Kyung Hee University College of Medicine at Gangdong, Kyung Hee University College of Medicine, South Korea

Prof. Dr. Yong Ahn is a globally recognized leader in minimally invasive spine surgery. Having earned his MD and PhD from Seoul National University School of Medicine, Dr. Ahn has devoted his career to advancing surgical techniques that minimize patient recovery time and improve outcomes. Currently serving as President of Wooridul Spine Hospital, he also heads the Department of Neurosurgery at Armed Forces Chungpyung Hospital. Dr. Ahn’s distinguished contributions are acknowledged worldwide, as reflected in his inclusion in MARQUIS Who’s Who and receipt of the Albert Nelson Marquis Lifetime Achievement Award. He holds pivotal roles in several spine surgery societies, chairs editorial boards for prestigious journals, and actively shapes the field through extensive research and publication. His dedication and innovations make him an exemplary candidate for the Best Researcher Award.

Publication Profile

Orcid

Education

Prof. Dr. Yong Ahn completed both his MD and PhD at the prestigious Seoul National University School of Medicine in Korea. Beyond his medical degrees, he expanded his expertise internationally, becoming a Fellow of the American Board of Minimally Invasive Spinal Surgery and the Royal College of Physicians and Surgeons. His educational background is marked by a combination of rigorous academic training and a forward-looking vision for medical innovation. Dr. Ahn’s academic pursuits laid a strong foundation for his pioneering work in minimally invasive techniques and spinal endoscopy, fields in which he would later become a leading authority. His commitment to lifelong learning and professional development exemplifies the values necessary for outstanding contributions to medical science.

Experience

Dr. Yong Ahn has had an illustrious career, marked by leadership and innovation in spine surgery. He currently serves as the President of Wooridul Spine Hospital and as Head of Neurosurgery at Armed Forces Chungpyung Hospital. Dr. Ahn also plays critical roles in academic societies, including being Chairperson of the Korean Endoscopic Spine Surgery Society and Scientific Manager of the Korean Minimally Invasive Spine Surgery Society. His expertise extends to national policy, where he serves on the Inter-Ministerial Evaluation Committee for national R&D projects. As Editor-in-Chief of JMISST-Video and an editorial board member of European Spine Journal, Biomed Research International, and PLOS One, he influences scientific communication globally. His experience is distinguished by a balance between surgical excellence, academic leadership, and contributions to national and international healthcare systems.

Awards and Honors

Prof. Dr. Yong Ahn’s outstanding achievements have been recognized through numerous prestigious awards. He received the Gachon University President’s Special Award for Research Excellence in 2020, honoring his significant research contributions. In 2018, he was awarded the Albert Nelson Marquis Lifetime Achievement Award, further confirming his global impact. Dr. Ahn’s inclusion in the MARQUIS Who’s Who reflects his longstanding influence and excellence in the field of spine surgery. His leadership positions within various professional societies and editorial roles also signify peer recognition of his professional authority and contributions. Each award not only celebrates his past accomplishments but also highlights his continuing commitment to advancing medical science and patient care.

Research Focus

Dr. Yong Ahn’s research focuses primarily on minimally invasive spine surgery and endoscopic procedures. He is a pioneer in developing techniques that allow complex spinal conditions to be treated with reduced surgical trauma, faster recovery, and improved patient outcomes. His studies address critical topics such as the learning curve associated with minimally invasive techniques, surgical complications like dural tears, and innovations in endoscopic decompression procedures. Dr. Ahn’s research bridges clinical practice and technological advancement, making significant strides in the refinement of surgical methods. As an editor and author of core textbooks in his field, he also contributes to education and knowledge dissemination. His commitment to evidence-based practice ensures that his research directly benefits both the scientific community and patients worldwide.

Publication Top Notes

Magnetic Resonance Imaging Predictors of Surgical Difficulty in Transforaminal Endoscopic Lumbar Discectomy for Far-Lateral Disc Herniation Under Local Anesthesia

A Commentary on β€œFull-Endoscopic Resection of a Lumbar Intradural Tumor (Schwannoma): Video Case Report and Description of the Surgical Technique”

Transforaminal Endoscopic Lumbar Foraminotomy for Iatrogenic Foraminal Stenosis Following Vertebroplasty

Access Pain During Transforaminal Endoscopic Lumbar Discectomy for Foraminal or Extraforaminal Disc Herniation

Access Pain during Transforaminal Endoscopic Lumbar Discec-Tomy for Foraminal or Extraforaminal Disc Herniation

Learning Curve for Endoscopic Transsphenoidal Surgery: A Systematic Review and Meta-Analysis

Bruno Songel Sanchis | Medicine and Health Sciences | Best Review Paper Award

Published on by Research Hypothesis

Bruno Songel Sanchis | Medicine and Health Sciences | Best Review Paper Award

Mr Bruno Songel Sanchis, Hospital clΓ­nico San Carlos, Spain

Mr. Bruno Songel Sanchis πŸŽ»πŸ‘“ is a versatile professional with dual expertise in music and vision sciences. Holding a Master’s in Optometry and Vision Sciences from the Complutense University of Madrid πŸŽ“, and a degree in Optics and Optometry from the University of Valencia, he seamlessly combines clinical acumen with research innovation. His extensive clinical experience spans Hospital ClΓ­nico San Carlos and FundaciΓ³n Salud Visual, focusing on cutting-edge myopia control, glaucoma diagnostics, and AI integration in ophthalmology πŸ€–πŸ§ . Beyond clinics, Bruno’s passion for community service is evident through his impactful volunteer roles and outreach projects 🫢. A talented cellist 🎢 and a committed scientist, he bridges the gap between art and science with grace and dedication. His systematic review on ocular manifestations in IBD showcases his research depth πŸ“„πŸ“Š. A creative thinker and empathetic clinician, Bruno is a promising contender for the Best Review Paper Award πŸ₯‡πŸ§¬.

Publication Profile

Orcid

Education

Bruno Songel Sanchis has a rich and interdisciplinary educational background πŸŽ“βœ¨. He earned his Professional Degree in Music (Violoncello) from the Professional Music Conservatory of Valencia 🎻, showcasing his artistic talents. He later pursued a Scientific Baccalaureate at San JosΓ© de Calasanz High School πŸ§ͺπŸ“˜. Bruno’s scientific journey led him to the University of Valencia, where he obtained his Degree in Optics and Optometry πŸ‘οΈπŸ“. Committed to advancing vision care, he continued with a Master’s Degree in Optometry and Vision Sciences at the prestigious Complutense University of Madrid πŸ‘“πŸ”¬. He’s currently engaged in Project Efficiency Boost (2025–present), enhancing clinical productivity through AI and innovation πŸš€πŸ€–. His academic versatility reflects both analytical rigor and creativity, a rare blend that empowers his impactful work in clinical practice and scientific research πŸ§ πŸ“š.

Experience

Bruno has extensive hands-on experience in both clinical and research settings πŸ₯πŸ”¬. He served as a Clinical Optometrist at Hospital ClΓ­nico San Carlos (Madrid), rotating across subspecialties like myopia, retina, glaucoma, and cataracts πŸ‘οΈπŸ’‰. He contributed to pivotal research on myopia control with Atropine and later as a Clinical Research Technician at IdISSC, focused on the β€˜LYDIA project’ developing AI diagnostic tools πŸ€–πŸ“Š. His role as a Product Specialist marked a major milestoneβ€”implementing Europe’s first AI-powered ophthalmic imaging system at La Paz Hospital πŸ₯✨. Earlier, he worked at Γ“ptica Universitaria and Alain Afflelou, gaining practical skills in optometry, sales, and customer care πŸ› οΈπŸ›οΈ. Bruno also holds a current role at FundaciΓ³n Salud Visual (Funsavi), continuing his clinical contributions while mentoring others. These experiences shape him into a well-rounded professional with deep clinical knowledge, technical skills, and patient-centered care focus πŸ‘“πŸ«Ά.

Awards and Honors

Bruno Songel Sanchis has garnered multiple honors for both creativity and scientific excellence πŸ†πŸ“š. He won 1st prize in the UV Creative Outreach Project (2021) for innovative public science engagement πŸŽ¨πŸ’‘. At the UVemprΓ©n Startup – Crea Awards, he secured 3rd position for his entrepreneurial vision in healthcare πŸ”¬πŸš€. His musical talents earned him an Honorable Mention Diploma at an International Music Seminar, reflecting his multifaceted abilities πŸŽΆπŸ…. He was also a Finalist in the MOTIVEM UV Awards, acknowledging his academic initiative and leadership πŸ“˜πŸ‘. As a Rapporteur at the SIYO 2022 Congress for Young Optometrists, he showcased his ability to bridge science and communication πŸ—£οΈπŸ“Š. His certifications from the London School of Hygiene and Tropical Medicine in public health ophthalmology further validate his global competence in preventing blindness and tackling ocular diseases on an international level πŸŒπŸ‘οΈ.

Research Focus

Bruno Songel Sanchis’s research focuses on clinical optometry, ocular disease prevention, and artificial intelligence applications in ophthalmology πŸ§ πŸ‘οΈπŸ€–. His major interests include myopia control, particularly using Atropine-based treatments, and early detection of age-related macular degeneration and glaucoma through AI-powered diagnostic systems πŸ§¬πŸ“ˆ. In collaboration with top-tier hospitals and research institutions, Bruno played a pivotal role in developing multi-diagnostic tools and conducting clinical trials on visual pathologies. His review on ocular extraintestinal manifestations in inflammatory bowel disease (IBD) offers critical insights into interdisciplinary patient care πŸ“„πŸ©Ί. A blend of practical clinical work and technical innovation defines his approach, with the goal of improving accessibility and effectiveness of vision care globally 🌐✨. His ongoing contributions to AI integration, coupled with community eye health initiatives, make him a forward-thinking optometrist and researcher committed to impactful, data-driven healthcare advancements πŸ©»πŸ“Š.

Publication Top Notes

Analysis of the Incidence of Ocular Extraintestinal Manifestations in Inflammatory Bowel Disease Patients: A Systematic Review (2024)

 

Joseph M Pappachan | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Joseph M Pappachan | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Joseph M Pappachan, Manchester Metropolitan University, United Kingdom

Prof. Dr. Joseph M. Pappachan is an internationally acclaimed endocrinologist and physician-scientist with profound contributions to metabolic and endocrine disorders. With over two decades of clinical, academic, and research experience, he currently serves at the Department of Endocrinology, Amrita Institute of Medical Sciences, India. His work bridges the gap between clinical practice and groundbreaking research, particularly in diabetes, obesity, metabolic syndrome, and endocrine hypertension. πŸ“Š He has authored numerous high-impact publications and book chapters, and actively contributes to peer-reviewed journals as an editor and reviewer. Prof. Pappachan’s research is widely cited, reflecting his global influence in the field. 🌍 Known for his mentorship and academic leadership, he has trained many budding endocrinologists and researchers. His dedication to innovation and translational research has earned him multiple accolades and fellowships. πŸ§ͺ A dynamic scholar and clinician, Prof. Pappachan embodies excellence, integrity, and impact in the medical research community.

Publication Profile

Google Scholar

Education

Prof. Dr. Joseph M. Pappachan holds an MBBS degree from Government Medical College, Calicut, and completed his MD in Internal Medicine from Government Medical College, Trivandrum. πŸ₯ He further specialized in Endocrinology with a DM from the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi. πŸ“˜ In pursuit of global medical standards, he earned Membership of the Royal College of Physicians (MRCP) in the UK and became a Fellow of the Royal College (FRCP) and Fellow of the American College of Endocrinology (FACE). πŸŽ–οΈ Prof. Pappachan has also undergone advanced training in endocrinology and diabetes in the United Kingdom and Europe, further honing his expertise in clinical research and metabolic diseases. 🌍 His commitment to lifelong learning is evident in his pursuit of continuing medical education and participation in international research fellowships, solidifying his position as an educator and research innovator in the medical sciences.

Experience

With over 20 years in clinical practice and academic research, Prof. Pappachan has served in leading institutions in India and the UK. πŸ₯ He is currently a Senior Consultant and Professor at the Department of Endocrinology, Amrita Institute of Medical Sciences, Kochi. Previously, he held several academic positions in NHS hospitals and universities across the United Kingdom, where he actively participated in clinical trials and interdisciplinary research. 🌐 His professional journey includes experience in tertiary referral centers for complex endocrine and metabolic disorders. Prof. Pappachan is a sought-after speaker in national and international medical conferences and frequently leads CME programs for physicians. πŸ—£οΈ He also serves on the editorial boards of prominent journals and contributes significantly to peer-review processes. πŸ–‹οΈ His extensive experience in patient care, medical education, and translational research makes him a respected authority in endocrinology worldwide.

Awards and Honors

Prof. Pappachan’s excellence in research has been recognized through numerous awards, fellowships, and international honors. πŸ… He has received the Fellowship of the Royal College of Physicians (FRCP), Fellowship of the American College of Endocrinology (FACE), and prestigious research grants for his work in metabolic disorders. πŸŽ“ His research publications have garnered thousands of citations, and he ranks among the top Indian scientists in endocrinology. πŸ“Š He has served as an expert panel member for international bodies and contributes to the development of clinical guidelines in diabetes and metabolic syndrome. 🌟 As an editorial board member and peer reviewer for several high-impact journals, his insight is valued across the medical research spectrum. 🧬 His outstanding contributions to patient care, research, and academic mentorship have earned him wide acclaim and nominations for top medical awards, making him a truly deserving candidate for the Best Researcher Award.

Research Focus

Prof. Pappachan’s research primarily centers on diabetes mellitus, obesity, metabolic syndrome, thyroid disorders, and hypertension, with a strong emphasis on the interplay between endocrine function and metabolic health. πŸ” His pioneering work investigates mechanisms of insulin resistance, neuroendocrine regulation, and cardiometabolic risk in various populations. His translational research explores clinical applications of novel diagnostic tools, therapeutic strategies, and biomarker discovery. πŸ§ͺ He has also examined sleep disorders and circadian rhythm disruptions in metabolic diseases and their implications for treatment outcomes. πŸŒ™ His extensive publications focus on patient-centered interventions and the development of global clinical protocols. πŸ“‹ With multidisciplinary collaboration, Prof. Pappachan continues to advance understanding in precision medicine and evidence-based endocrinology, contributing significantly to the global discourse on metabolic and endocrine diseases. 🌐 His research is transformative, clinically relevant, and instrumental in shaping modern endocrine care.

Publication Top Notes

Omega-3 fatty acids: a comprehensive review of their role in health and disease

Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management

Diabetes mellitus and stroke: a clinical update

Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis

High-dose cholecalciferol booster therapy is associated with a reduced risk of mortality in patients with COVID-19: a cross-sectional multi-centre observational study

Snakebite envenoming in Kerala, South India: clinical profile and factors involved in adverse outcomes

Male obesity-related secondary hypogonadism–pathophysiology, clinical implications and managementMedicine and Health Sciences

Esmaeil Mehraeen | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Esmaeil Mehraeen | Medicine and Health Sciences | Best Researcher Award

Dr Esmaeil Mehraeen, Khalkhal University of Medical Sciences, Iran

Dr. Esmaeil Mehraeen is an esteemed health informatics expert recognized for his contributions to medical research, particularly in health information management and digital health solutions. His research spans HIV self-management, telemedicine, AI in healthcare, and pandemic response strategies. A prolific author, he has published extensively on innovative healthcare technologies, ethical AI applications, and epidemiological assessments. His dedication to advancing medical informatics earned him recognition as the top researcher in Ardabil province in 2021. With a strong academic and executive background, he continues to shape the future of health informatics, making him an ideal candidate for the Best Researcher Award.

Publication Profile

Google Scholar

Education

Dr. Esmaeil Mehraeen is a dedicated expert in Health Information Management πŸ“ŠπŸ©Ί, earning his Ph.D. from Tehran University of Medical Sciences (2015-2018). His doctoral research focused on designing, developing, and evaluating a mobile and web-based intelligent self-management system for people living with HIV πŸ“±πŸ’‘. He previously completed an MSc in Medical Records Education (2010-2012) at the same university, where he explored information security in hospital information systems at Tehran and Shahid Beheshti Universities πŸ₯πŸ”. His academic journey began with a BSc in Medical Records (2005-2007) from Shahid Beheshti University of Medical Sciences πŸ“‘πŸ“š, laying the foundation for his expertise in health data management and security. With a strong background in digital health solutions and medical informatics, Dr. Mehraeen contributes to improving healthcare technology and patient self-management systems πŸ₯πŸ“². His work bridges the gap between healthcare and innovative digital tools, ensuring secure and efficient health information management πŸ”πŸ’».

Experience

Dr. Esmaeil Mehraeen is a dedicated academic and researcher in medical sciences πŸ₯πŸ“š. He has served as a Faculty Member at Khalkhal University of Medical Sciences (2018-2024) πŸ‘¨β€πŸ« and previously held the same role at Zabol University of Medical Sciences (2012-2015) and Ardabil University of Medical Sciences (2016-2018) πŸŽ“πŸ“–. His leadership roles include serving as Vice President of Education & Research at Khalkhal University (2019-2021) πŸ“ŠπŸ›, where he contributed to advancing academic programs. Additionally, he was Student Manager (2018-2019) πŸŽ“πŸ“‹ and Head of the Scientometric Department (2018) πŸ”πŸ“ˆ. Dr. Mehraeen has been an active Research & Educational Council Member across various universities in Iran πŸ“ŠπŸ”¬πŸ“š, fostering scientific collaboration and innovation. His extensive experience in medical education, research leadership, and scientometrics highlights his commitment to academic excellence and the advancement of healthcare sciences πŸ“–πŸ”¬πŸ₯.

Awards & Honors

Dr. Esmaeil Mehraeen is a distinguished researcher recognized as the Top Researcher in Ardabil Province (2021) πŸ†πŸŽ– for his outstanding contributions. His academic excellence began early, securing 1st place in the Ph.D. Entrance Exam (2015) πŸ₯‡πŸ“š and being honored as an Exemplary Student in his MSc Program (2011) πŸŽ“πŸ…. His dedication to research and education is evident through his active role as a member of Research & Educational Councils (2010-2021) πŸ›πŸ“–, shaping academic policies and fostering innovation. Additionally, he played a key role in student research, serving as a member of the Student Research Committee at Iran University of Medical Sciences (2010-2011) πŸ”¬πŸ‘¨β€πŸ”¬πŸ“š, contributing significantly to medical advancements. His commitment to academic excellence and research leadership continues to inspire students and scholars alike. πŸŒŸπŸ“–

Research Focus

Dr. Esmaeil Mehraeen is a dedicated expert in health information management, medical informatics, and digital health solutions. πŸ₯πŸ’» His research spans AI-driven chatbots in healthcare πŸ€–πŸ₯, telemedicine innovations πŸ“‘πŸ“ž, and self-management systems for HIV patients πŸ₯πŸ“². He has contributed significantly to epidemiological studies on COVID-19 πŸ¦ πŸ“Š, providing valuable insights into public health responses. His work also delves into ethical considerations in AI healthcare applications βš–οΈπŸ€–, health system security πŸ”, and data-driven decision-making in public health πŸ“ŠπŸŒ. Through systematic reviews and meta-analyses πŸ“šπŸ”, Dr. Mehraeen influences global health informatics research, shaping policies and advancing medical technologies. His interdisciplinary approach fosters innovation, improving healthcare accessibility and efficiency worldwide. πŸŒπŸ’‘πŸ‘¨β€πŸ”¬

Publication Top Notes

Predictors of mortality in patients with COVID-19–a systematic review

Late complications of COVID-19; a systematic review of current evidence

Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID‑19): a review of current evidence

The relationship between COVID‐19 viral load and disease severity: A systematic review

The challenges of E‑learning system: Higher educational institutions perspective

Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review

Effects of COVID-19 prevention procedures on other common infections: a systematic review

Post-synthetic functionalization of the metal-organic framework: Clean synthesis, pollutant removal, and antibacterial activity

 

Mohamed Hassan | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Mohamed Hassan | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr Mohamed Hassan, Tulane University School of Medicine, United States

Assist. Prof. Dr. Mohamed Hassan is a distinguished researcher in molecular biology, tumor biology, and virology 🧬. His groundbreaking work focuses on tumor progression, cancer stem cell biology, and innovative therapeutic strategies 🎯. With an extensive portfolio of high-impact publications πŸ“„ and supervised doctoral candidates πŸŽ“, his research significantly contributes to understanding melanoma resistance, non-receptor tyrosine kinases, and immune checkpoint inhibitors πŸ₯. He has collaborated with leading international institutions, enriching the field with novel discoveries in oncology πŸ”¬. His contributions extend beyond research, fostering the next generation of scientists and improving clinical oncology outcomes πŸ₯.

Publication Profile

Orcid

Education

Dr. Mohamed Hassan earned his Ph.D. in Molecular Biology πŸ… from the University Hospital of DΓΌsseldorf, Germany (2001), where his research focused on the interference of the Hepatitis C Virus (HCV) core protein with intracellular signal transduction in liver cells 🦠. He holds an M.Sc. in Molecular Biology πŸ“– from the University of DΓΌsseldorf (1996), with a thesis on identifying and characterizing differentially expressed cDNA libraries in Plasmodium malaria chabaudi immune mice πŸ§ͺ. His academic journey began with a B.Sc. in Biological Sciences 🏫 from Zagazig University, Egypt, and the University of DΓΌsseldorf (1983). His expertise in cancer biology, virology, and molecular research πŸ“Š has established him as a leading researcher in the field.

Experience

Assist. Prof. Dr. Mohamed Hassan is a dedicated cancer researcher with extensive expertise in tumor progression, oncological drug resistance, and precision medicine πŸ”¬πŸ’Š. He is currently a Senior Postdoctoral Fellow at the Institut National de la SantΓ© et de la Recherche MΓ©dicale, University of Strasbourg, France (2018-2025) πŸ₯. Previously, he served as a Research Assistant Professor at Tulane University School of Medicine, USA (2016-2018) πŸŽ“, and a Postdoctoral Fellow at the University Hospital of DΓΌsseldorf, Germany (2002-2004). His groundbreaking work focuses on identifying biomarkers and developing targeted therapies to enhance cancer treatment worldwide 🌍🧬.

Research Focus

Assist. Prof. Dr. Mohamed Hassan’s research focuses on tumor progression, cancer stem-like cells, and treatment resistance 🧬. His work delves into melanoma’s resistance to standard therapies 🎯, mechanisms of tumor progression and immune evasion πŸ₯, and targeting cancer stem-like cells to enhance treatment efficacy πŸ’Š. He investigates the role of non-receptor tyrosine kinases in oncogenesis πŸ”¬ and explores immune checkpoint inhibitors and their associated cutaneous adverse effects βš•οΈ. Additionally, his discovery of antimicrobial peptides holds promise for clinical applications 🦠. His contributions drive novel therapeutic strategies, improving cancer treatment outcomes worldwide 🌍.

Publication Top Notes

Reduction of Prostate Cancer Risk: Role of Frequent Ejaculation-Associated Mechanisms

Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of Occurrence

Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and Resistance

<i>hTERT</i> Epigenetics Provides New Perspectives for Diagnosis and Evidence-Based Guidance of Chemotherapy in Cancer

CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance

Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells

Induction of Antimicrobial Protein S100A15 Expression by Oral Microbial Pathogens Is Toll-like Receptors-Dependent Activation of c-Jun-N-Terminal Kinase (JNK), p38, and NF-ΞΊB Pathways

 

 

 

Wei Liu | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Wei Liu | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Wei Liu Hunan, University of Chinese Medicine, China

Prof. Dr. Wei Liu is a distinguished scholar in Artificial Intelligence πŸ€–, Medical Informatics πŸ₯, and Intelligent Software Engineering πŸ’», serving as Deputy Dean at Hunan University of Chinese Medicine. With a Ph.D. in Engineering πŸŽ“, he has made groundbreaking contributions through 100+ research papers πŸ“„ (30+ indexed in SCI/EI), 2 monographs πŸ“š, and 9 textbooks πŸ“–. His 30+ software copyrights πŸ’‘ and leadership in 20+ major projects πŸš€, including collaborations with Huawei and national research foundations, solidify his expertise. As a Young Backbone Teacher of Hunan Province, he also excels in mentoring, guiding students to 300+ awards πŸ…, including 10+ national gold prizes πŸ†. His teaching innovation has earned him national and provincial-level honors, while his contributions to Traditional Chinese Medicine (TCM) Informatics 🌿 further highlight his multidisciplinary excellence. Recognized as a National Certified System Architect πŸ—οΈ, SCI journal reviewer 🧐, and a member of CCF, ACM, and CAIS, Prof. Liu is a true leader in his field.

Publication Profile

Scopus

Education

Prof. Dr. Wei Liu holds a Ph.D. in Engineering (Computer Application Technology) πŸ–₯️ from a prestigious institution, where he specialized in Artificial Intelligence πŸ€– and Medical Informatics πŸ₯. His doctoral research focused on intelligent software systems, integrating machine learning πŸ“Š with healthcare applications 🏩. Prior to his Ph.D., he completed his Master’s degree πŸŽ“ in Computer Science, gaining deep expertise in data-driven decision-making πŸ’Ύ and intelligent algorithms πŸ”. His academic journey also includes undergraduate studies in Software Engineering πŸ’‘, where he built a strong foundation in computational intelligence 🧠, biomedical computing πŸ₯, and software development πŸ’». With an interdisciplinary education spanning engineering, computer science, and informatics, Prof. Liu combines technical depth with practical innovation, making his academic background perfectly suited for pioneering AI-driven healthcare solutions πŸš‘. His commitment to education πŸ“š continues as he mentors students and professionals in next-generation AI research and applications πŸ€–πŸ“Š.

Experience

Prof. Dr. Wei Liu serves as the Deputy Dean of the School of Informatics πŸ›οΈ at Hunan University of Chinese Medicine, leading research in Artificial Intelligence πŸ€–, Medical Informatics πŸ₯, and Software Engineering πŸ’». As a Professor and Senior Engineer πŸ‘¨β€πŸ”¬, he supervises Master’s students πŸŽ“, guiding them in cutting-edge AI research πŸš€. With a rich teaching career πŸ“š, he has developed three top-level provincial courses πŸŽ–οΈ and ranked 1st in the Hunan Provincial Teaching Competition πŸ†. His industry collaborations with Huawei and leadership in 20+ national projects πŸ—οΈ highlight his practical impact 🌍. He actively contributes as a Vice President of the Hunan Association for TCM Informatics 🌿 and serves on multiple national AI and computing committees 🀝. His work as an SCI journal reviewer 🧐 and National Certified System Architect πŸ—οΈ ensures that his research, teaching, and innovation continue to shape the future of AI-driven medical solutions πŸ”¬.

Awards & Honors

Prof. Dr. Wei Liu is a distinguished researcher and educator 🌟, renowned for his contributions to AI, medical informatics, and teaching innovation πŸ“š. His accolades include the National Teaching Innovation Competition Second Prize πŸ† (2024), 1st Place in the Hunan Provincial Teaching Competition πŸŽ–οΈ, and the National TCM Informatics Teaching Gold Prize πŸ…. He has been honored as the β€œMost Knowledgeable Young Teacher” in Hunan Province πŸ† and recognized as a Young Backbone Teacher πŸ‘¨β€πŸ«. A recipient of the Huawei Industry-Academia Collaboration Excellence Award πŸ…, he also serves as an Executive Member of National AI Committees πŸ€–. His mentorship has led students to win 300+ awards πŸ†, including over 10 national gold prizes πŸ₯‡. As a pioneer in AI-driven medical technologies 🌍, his impact extends across academia and industry πŸš€.

Research Focus

Prof. Dr. Wei Liu’s research spans Artificial Intelligence πŸ€–, Medical Informatics πŸ₯, and Intelligent Software Engineering πŸ’», focusing on AI-driven healthcare solutions πŸ“Š, big data analysis 🏩, and intelligent diagnosis πŸ₯. His expertise includes AI-based disease prediction, NLP for medical data πŸ“œ, deep learning for medical imaging πŸ§ πŸ“Έ, and IoT-driven smart healthcare πŸš‘. Integrating AI with Traditional Chinese Medicine πŸŒΏπŸ€–, he pioneers innovative patient care solutions. With 30+ software copyrights πŸ’‘, 100+ high-impact publications πŸ“„, and national-level projectsβ€”including Huawei collaborations πŸš€β€”his work enhances precision medicine, diagnostics, and medical software applications 🌍, revolutionizing healthcare technology.

Publication Top Notes

Recognition of Hand-Drawn Hydrocarbon Structure Formulas Using Anchor-Free Detector

Classification of cold and hot medicinal properties of Chinese herbal medicines based on graph convolutional network

ChemReco: automated recognition of hand-drawn carbon–hydrogen–oxygen structures using deep learning

SQCS: A sustainable quality control system for spatial crowdsourcing via three-party evolutionary game: Theory and practice

Truth based three-tier Combinatorial Multi-Armed Bandit ecosystems for mobile crowdsensing

YoDe-Segmentation: automated noise-free retrieval of molecular structures from scientific publications

 

Tracey Young-Sharma | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Tracey Young-Sharma | Medicine and Health Sciences | Best Researcher Award

Dr Tracey Young-Sharma, Ministry of Health and Medical Service FIji, Fiji

Dr. Tracey Young-Sharma is an accomplished physician specializing in internal medicine and antimicrobial resistance (AMR). She holds a Masters of Medicine from Fiji National University (2019) and has been awarded the ASID GOLD Medal. Currently an AMR consultant for the World Health Organization, Dr. Young-Sharma has held various roles, including Consultant Physician and Registrar at CWM Hospital. She has contributed to multiple studies on antimicrobial resistance and its impact in Fiji, with notable publications in The Lancet and JGAR. Dr. Young-Sharma is also the Chairperson of the Infection Prevention Control Committee at CWMH. πŸ₯πŸ¦ πŸ“šπŸŒ

Publication Profile

Scopus

Education

Dr. Tracey Young-Sharma is a highly accomplished medical professional with a strong background in Internal Medicine. She completed her Masters of Medicine in Internal Medicine at Fiji National University in 2019. Prior to that, she earned a Postgraduate Diploma in Internal Medicine in 2016 and a Bachelor’s degree in Medicine and Surgery from the Fiji School of Medicine in 2010. Dr. Young-Sharma has been recognized for her excellence in the field, receiving the prestigious Australian Society of Infectious Disease (ASID) GOLD Medal Award πŸ…πŸ’‰. Her dedication to improving healthcare continues to inspire and impact the medical community. πŸ‘©β€βš•οΈπŸŒŸ

Experience

Dr. Tracey Young-Sharma is an AMR consultant for the World Health Organisation (WHO) since August 2024 🌍. Previously, she served as a Consultant Physician at CWM Hospital (2022-2024) πŸ₯ and as a Registrar at the same hospital from 2016 to 2021. Prior to that, she worked as a Registrar in Internal Medicine at Labasa Hospital in 2015 🩺. Dr. Young-Sharma began her career as a Medical Officer at Levuka Hospital and Koro Health Centre (2012-2014) πŸ₯ and completed her internship at CWM Hospital in 2011. Her extensive experience spans various medical roles, contributing to healthcare development. πŸ‘©β€βš•οΈπŸŒΏ

Professional MembershipsΒ 

Dr. Tracey Young-Sharma is a dedicated healthcare professional with strong affiliations in the medical field. She is an Associate Member of the Internal Medicine Society of Australia and New Zealand and a member of the Internal Medicine Organisation of the Pacific. Additionally, Dr. Young-Sharma is part of the International Women’s Association, the Fiji Medical Association, and the Australasian College of Infection Prevention and Control. In 2022, she served as the Chairperson of the Infection Prevention and Control Committee at CWMH. Her active roles reflect her commitment to advancing healthcare and fostering collaboration in the medical community. πŸŒπŸ‘©β€βš•οΈπŸ’‰πŸ©Ί

Research Focus

Dr. Tracey Young-Sharma’s research primarily focuses on antimicrobial resistance (AMR), particularly in resource-limited settings like Fiji. Her work involves genomic surveillance and epidemiological studies to understand the spread of carbapenem-resistant organisms and other multidrug-resistant pathogens. Dr. Young-Sharma’s studies also emphasize the impact of AMR on healthcare outcomes, including attributable mortality and length of hospital stays. She is also involved in improving healthcare workers’ knowledge and readiness to combat AMR through intervention studies. Her research aims to inform public health strategies and healthcare policies in the context of global AMR challenges. πŸ¦ πŸ”¬πŸŒπŸ‘©β€πŸ”¬πŸ’‰

Publication Top Notes

Successful management of a multi-species outbreak of carbapenem-resistant organisms in Fiji: a prospective genomics-enhanced investigation and response

Knowledge, attitudes, and readiness about critical antimicrobial resistant organisms among healthcare workers at colonial war memorial hospital in Fiji: a pre and post intervention study

The epidemiology of enterococci in a tertiary hospital and primary healthcare facilities in Fiji (2019–2022)

The changing epidemiology of antimicrobial resistance in Fiji: a descriptive analysis of antimicrobial susceptibility and trends of endemic and emerging pathogens, 2019–2022

Attributable mortality and excess length of stay associated with third-generation cephalosporin-resistant Enterobacterales bloodstream infections: a prospective cohort study in Suva, Fiji

Epidemiology, antimicrobial resistance and outcomes of Staphylococcus aureus bacteraemia in a tertiary hospital in Fiji: A prospective cohort study

Russka Shumnalieva | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Russka Shumnalieva | Medicine and Health Sciences | Best Researcher Award

Assist Prof Dr Russka Shumnalieva, Medical University-Sofia, Bulgaria, Bulgaria

Based on the details provided, Assist. Prof. Dr. Russka Shumnalieva appears to be a strong candidate for a Best Researcher Award.

Publication profileΒ 

Orcid

  1. Expertise in Rheumatology: Dr. Shumnalieva has extensive experience in rheumatology, working at the largest university clinic for rheumatic diseases in Bulgaria. Her PhD thesis focuses on epigenetic modifications and their relation to rheumatic diseases, demonstrating in-depth research in disease mechanisms.
  2. Clinical Integration: Her research not only addresses theoretical aspects but also their application in clinical practice. Her work includes utilizing advanced techniques such as MSUS, capillaroscopy, and mini-invasive arthroscopy, showcasing her hands-on expertise in treating and monitoring patients.
  3. Translational Medicine Experience: Her fellowship at GBRC (Glasgow) and AMC (Amsterdam) provided her valuable experience in translational medicine, bridging the gap between laboratory research and clinical application.
  4. COVID-19 Research Contributions: Dr. Shumnalieva has co-authored significant research papers in top-tier journals, contributing to global studies on COVID-19 and its impact on autoimmune diseases, which underscores her relevance in current medical challenges.
  5. Multidisciplinary Collaborations: Her publications involve multidisciplinary, international collaborations on critical topics such as coronary artery diseases in vasculitides, multimorbidity in inflammatory myopathies, and lung involvement in systemic sclerosis.
  6. Public Health and Patient Care: With a Master’s in Public Health, Dr. Shumnalieva also explores the correlation between risk factors and rheumatic diseases, adding a valuable population health perspective to her research.
  7. Publication Record: With a solid portfolio of peer-reviewed articles in highly respected journals like Rheumatology International and International Journal of Rheumatic Diseases, Dr. Shumnalieva’s research addresses critical issues like the effect of multimorbidity on quality of life and disease flares post-COVID-19 infection.

    Publication top notes

    Flares of autoimmune rheumatic disease following COVID-19 infection: Observations from the COVAD study

    Management of Coronary Artery Diseases in Systemic Vasculitides: Complications and Strategies

    The impact of multimorbidity on QoL in inflammatory myopathies: COVAD cluster analysis

    Lung Involvement in Systemic Sclerosisβ€”From Pathogenesis to Prediction

    Exploring the Role of the Microbiome in Rheumatoid Arthritisβ€”A Critical Review

    In the Pursuit of Precision: Novel Target Therapies Revolutionizing SLE Care

    Conclusion

    Dr. Shumnalieva’s extensive research background, innovative approaches to rheumatology, and contributions to understanding the intersection of autoimmune diseases and COVID-19 make her a standout candidate for the Best Researcher Award.